Biotest Aktiengesellschaft reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was EUR 252.8 million compared to EUR 107.7 million a year ago. Net income was EUR 114.4 million compared to net loss of EUR 14.3 million a year ago.
For the nine months, sales was EUR 500.3 million compared to EUR 360.8 million a year ago. Net income was EUR 88.4 million compared to net loss of EUR 34.2 million a year ago.